XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Statements of Operations - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating expenses:    
Research and development $ 2,809,791 $ 2,389,583
General and administrative 3,104,071 839,627
Total operating expenses 5,913,862 3,229,210
Operating loss (5,913,862) (3,229,210)
Other income:    
Interest income 19,649 197
Grant income   29,340
Total other income 19,649 29,537
Loss before income taxes (5,894,213) (3,199,673)
Income tax expense (benefit) 0 0
Net loss $ (5,894,213) $ (3,199,673)
Basic loss per common share $ (0.72) $ (0.46)
Diluted loss per common share $ (0.72) $ (0.46)
Weighted average number of common shares outstanding, basic 8,157,445 6,920,622
Weighted average number of common shares outstanding, diluted 8,157,445 6,920,622